Worldwide Cancer Research
Latest income
£10.5m
Latest spending
£11.8m
Accounts read
FY2025
Form
Company (the charity is registered with Companies House)
Financial health, per FY2025 accounts
The accounts state that the charity reported a net deficit of £0.2 million after investment gains, driven by a shortfall in legacy income. However, the trustees report a strong reserves position with free reserves of £4.0 million and liquid assets sufficient to pass their reserve test by a margin of £3.8 million. The charity maintains adequate resources to continue in operational existence for at least 12 months.
What the accounts disclose
Highest-paid employee band: £100,000 - £120,000
“£100,000 - £120,000 1” — page 30
Per FY2025 accounts as filed with OSCR.
Related-party transaction: Professor Jim Norman, a director, received a grant of £217,531 awarded in Dec 2021 as co-applicant; £nil remained payable at year end.
“In December 2021, prior to his appointment as a Director, a grant of £217,531 was awarded to Professor Jim Norman as a co-applicant for a three year research project that commenced in March 2022. At the year end, £nil (2024: £62,338) remained payable on this grant award.” — page 38
Per FY2025 accounts as filed with OSCR.
Reserves policy: liquid assets must be greater than 24 months of projected cash outflows for grant commitments plus 6 months of projected operating expenses (held: £4.0m)
“The reserve test requires that liquid assets (cash and investments) must be greater than 24 months of projected cash outflows for grant commitments plus 6 months of projected operating expenses.” — page 10
Per FY2025 accounts as filed with OSCR.
Largest income source: Regular giving (52% of income)
“Regular giving 5,396,523” — page 27
Per FY2025 accounts as filed with OSCR.
Independent examiner: Henderson Loggie LLP
Per FY2025 accounts as filed with OSCR.